{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:59:28Z","timestamp":1776322768522,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glycolic acid is the smallest alpha hydroxy acid and widely used for skincare applications, including to treat acne vulgaris. Oftentimes, high concentrations of glycolic acid (~20\u201350 vol%) are incorporated into chemical peels to reduce acne-related inflammation while there is an outstanding need to determine to what extent glycolic acid can potently inhibit <jats:italic>Cutibacterium acnes<\/jats:italic> (formerly known as <jats:italic>Propionibacterium acnes<\/jats:italic>), which is a Gram-positive bacterium implicated in acne pathogenesis. Herein, we report that glycolic acid exhibits pH-dependent antibacterial activity against <jats:italic>C. acnes<\/jats:italic> and mechanistic studies identified that the nonionic form of glycolic acid is more active than the anionic form. The degree of antibacterial activity, including minimum bactericidal concentration (MBC), of glycolic acid was evaluated in the pH range of 3 to 4.5, and the greatest potency was observed at pH 3. In light of skincare formulation needs, we selected the pH 3.5 condition for further testing and determined that glycolic acid kills <jats:italic>C. acnes<\/jats:italic> cells by disrupting bacterial cell membranes. While most conventional treatments involve high concentrations of glycolic acid (&gt;20%), our findings support the potential of developing anti-acne formulations with glycolic acid concentrations as low as 0.2% and with pH conditions that are suitable for over-the-counter applications.<\/jats:p>","DOI":"10.1038\/s41598-020-64545-9","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T10:05:01Z","timestamp":1588586701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["pH-Dependent Antibacterial Activity of Glycolic Acid: Implications for Anti-Acne Formulations"],"prefix":"10.1038","volume":"10","author":[{"given":"Elba R.","family":"Valle-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A.","family":"Jackman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo Kyeong","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Mokrzecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam-Joon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"64545_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","volume":"379","author":"HC Williams","year":"2012","unstructured":"Williams, H. C., Dellavalle, R. P. & Garner, S. Acne vulgaris. The Lancet 379, 361\u2013372 (2012).","journal-title":"The Lancet"},{"key":"64545_CR2","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMcp1702493","volume":"379","author":"AL Zaenglein","year":"2018","unstructured":"Zaenglein, A. L. Acne vulgaris. N. Engl. J. Med. 379, 1343\u20131352 (2018).","journal-title":"N. Engl. J. Med."},{"key":"64545_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00403-019-01908-x","volume":"311","author":"T-X Cong","year":"2019","unstructured":"Cong, T.-X. et al. From pathogenesis of acne vulgaris to anti-acne agents. Arch. Dermatol. Res. 311, 337\u2013349 (2019).","journal-title":"Arch. Dermatol. Res."},{"key":"64545_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.clindermatol.2009.03.012","volume":"28","author":"C Dessinioti","year":"2010","unstructured":"Dessinioti, C. & Katsambas, A. D. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies. Clin. Dermatol. 28, 2\u20137 (2010).","journal-title":"Clin. Dermatol."},{"key":"64545_CR5","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/ijd.13282","volume":"55","author":"HH Kwon","year":"2016","unstructured":"Kwon, H. H. & Suh, D. H. Recent progress in the research about Propionibacterium acnes strain diversity and acne: pathogen or bystander? Int. J. Dermatol. 55, 1196\u20131204 (2016).","journal-title":"Int. J. Dermatol."},{"key":"64545_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jdv.15043","volume":"32","author":"B Dr\u00e9no","year":"2018","unstructured":"Dr\u00e9no, B. et al. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. J. Eur. Acad. Dermatol. Venereol. 32, 5\u201314 (2018).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"64545_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2165\/11632500-000000000-00000","volume":"13","author":"T Simonart","year":"2012","unstructured":"Simonart, T. Newer approaches to the treatment of acne vulgaris. Amer. J. Clin. Dermatol. 13, 357\u2013364 (2012).","journal-title":"Amer. J. Clin. Dermatol."},{"key":"64545_CR8","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1111\/jdv.12989","volume":"29","author":"M Leccia","year":"2015","unstructured":"Leccia, M. et al. Topical acne treatments in Europe and the issue of antimicrobial resistance. J. Eur. Acad. Dermatol. Venereol. 29, 1485\u20131492 (2015).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"64545_CR9","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S1473-3099(15)00527-7","volume":"16","author":"TR Walsh","year":"2016","unstructured":"Walsh, T. R., Efthimiou, J. & Dr\u00e9no, B. Systematic review of antibiotic resistance in acne: an increasing topical and oral threat. Lancet Infect. Dis. 16, e23\u2013e33 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"64545_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.clindermatol.2016.10.008","volume":"35","author":"C Dessinioti","year":"2017","unstructured":"Dessinioti, C. & Katsambas, A. Propionibacterium acnes and antimicrobial resistance in acne. Clin. Dermatol. 35, 163\u2013167 (2017).","journal-title":"Clin. Dermatol."},{"key":"64545_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-50746-4","volume":"9","author":"MA Blaskovich","year":"2019","unstructured":"Blaskovich, M. A., Elliott, A. G., Kavanagh, A. M., Ramu, S. & Cooper, M. A. In vitro antimicrobial activity of acne drugs against skin-associated bacteria. Sci. Rep. 9, 1\u20138 (2019).","journal-title":"Sci. Rep."},{"key":"64545_CR12","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1038\/jid.2009.93","volume":"129","author":"T Nakatsuji","year":"2009","unstructured":"Nakatsuji, T. et al. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J. Invest. Dermatol. 129, 2480\u20132488 (2009).","journal-title":"J. Invest. Dermatol."},{"key":"64545_CR13","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3390\/ijms19041114","volume":"19","author":"BK Yoon","year":"2018","unstructured":"Yoon, B. K., Jackman, J. A., Valle-Gonz\u00e1lez, E. R. & Cho, N.-J. Antibacterial free fatty acids and monoglycerides: biological activities, experimental testing, and therapeutic applications. Int. J. Mol. Sci. 19, 1114 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"64545_CR14","doi-asserted-by":"publisher","first-page":"13745","DOI":"10.1021\/acs.langmuir.8b02536","volume":"34","author":"ER Valle-Gonza\u0301lez","year":"2018","unstructured":"Valle-Gonza\u0301lez, E. R. et al. Characterizing how acidic pH conditions affect the membrane-disruptive activities of lauric acid and glycerol monolaurate. Langmuir 34, 13745\u201313753 (2018).","journal-title":"Langmuir"},{"key":"64545_CR15","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.annder.2017.08.011","volume":"144","author":"F Poli","year":"2017","unstructured":"Poli, F., Claudel, J.-P., Auffret, N., Leccia, M.-T. & Dr\u00e9no, B. Cosmetics and topical medications in acne: Where is the boundary? Ann. Dermatol. Venereol. 144, 768\u2013775 (2017).","journal-title":"Ann. Dermatol. Venereol."},{"key":"64545_CR16","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/jdv.13579","volume":"30","author":"E Araviiskaia","year":"2016","unstructured":"Araviiskaia, E. & Dr\u00e9no, B. The role of topical dermocosmetics in acne vulgaris. J. Eur. Acad. Dermatol. Venereol. 30, 926\u2013935 (2016).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"64545_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/00128071-200001020-00002","volume":"1","author":"RC Tung","year":"2000","unstructured":"Tung, R. C., Bergfeld, W. F., Vidimos, A. T. & Remzi, B. K. \u03b1-Hydroxy acid-based cosmetic procedures. Amer. J. Clin. Dermatol. 1, 81\u201388 (2000).","journal-title":"Amer. J. Clin. Dermatol."},{"key":"64545_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2147\/CCID.S34029","volume":"6","author":"J Sharad","year":"2013","unstructured":"Sharad, J. Glycolic acid peel therapy\u2013a current review. Clin., Cosmet. Invest. Dermatol. 6, 281 (2013).","journal-title":"Clin., Cosmet. Invest. Dermatol."},{"key":"64545_CR19","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/dsu.12417","volume":"40","author":"C Kaminaka","year":"2014","unstructured":"Kaminaka, C., Uede, M., Matsunaka, H., Furukawa, F. & Yamomoto, Y. Clinical evaluation of glycolic acid chemical peeling in patients with acne vulgaris: a randomized, double-blind, placebo-controlled, split-face comparative study. Dermatol. Surg. 40, 314\u2013322 (2014).","journal-title":"Dermatol. Surg."},{"key":"64545_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1473-2165.2011.00572.x","volume":"10","author":"C Abels","year":"2011","unstructured":"Abels, C. et al. A 10% glycolic acid containing oil-in-water emulsion improves mild acne: a randomized double-blind placebo-controlled trial. J. Cosmet. Dermatol. 10, 202\u2013209 (2011).","journal-title":"J. Cosmet. Dermatol."},{"key":"64545_CR21","first-page":"32","volume":"5","author":"A Decker","year":"2012","unstructured":"Decker, A. & Graber, E. M. Over-the-counter acne treatments: a review. J. Clin. Aesthet. Dermatol. 5, 32 (2012).","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"64545_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2147\/CCID.S137788","volume":"11","author":"DE Castillo","year":"2018","unstructured":"Castillo, D. E. & Keri, J. E. Chemical peels in the treatment of acne: patient selection and perspectives. Clin., Cosmet. Invest. Dermatol. 11, 365 (2018).","journal-title":"Clin., Cosmet. Invest. Dermatol."},{"key":"64545_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1054\/mehy.1998.0788","volume":"53","author":"X Wang","year":"1999","unstructured":"Wang, X. A theory for the mechanism of action of the \u03b1-hydroxy acids applied to the skin. Med. Hypotheses 53, 380\u2013382 (1999).","journal-title":"Med. Hypotheses"},{"key":"64545_CR24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1346-8138.2011.01321.x","volume":"39","author":"Y Takenaka","year":"2012","unstructured":"Takenaka, Y., Hayashi, N., Takeda, M., Ashikaga, S. & Kawashima, M. Glycolic acid chemical peeling improves inflammatory acne eruptions through its inhibitory and bactericidal effects on Propionibacterium acnes. J. Dermatol. 39, 350\u2013354 (2012).","journal-title":"J. Dermatol."},{"key":"64545_CR25","doi-asserted-by":"publisher","first-page":"41S","DOI":"10.1177\/1091581813507090","volume":"32","author":"WF Bergfeld","year":"2013","unstructured":"Bergfeld, W. F. et al. Safety assessment of alpha hydroxy acids as used in cosmetics: Re-review. Int. J. Toxicol. 32, 41S\u201364S (2013).","journal-title":"Int. J. Toxicol."},{"key":"64545_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1473-2130.2004.00059.x","volume":"3","author":"RJ Yu","year":"2004","unstructured":"Yu, R. J. & Van Scott, E. J. Alpha-hydroxyacids and carboxylic acids. J. Cosmet. Dermatol. 3, 76\u201387 (2004).","journal-title":"J. Cosmet. Dermatol."},{"key":"64545_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0005-2736(98)00236-3","volume":"1416","author":"R Males","year":"1999","unstructured":"Males, R. & Herring, F. A 1H-NMR study of the permeation of glycolic acid through phospholipid membranes. Biochim. Biophys. Acta, Biomembr. 1416, 333\u2013338 (1999).","journal-title":"Biochim. Biophys. Acta, Biomembr."},{"key":"64545_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3389\/fmicb.2019.00801","volume":"10","author":"J Robertson","year":"2019","unstructured":"Robertson, J., McGoverin, C., Vanholsbeeck, F. & Swift, S. Optimisation of the protocol for the LIVE\/DEAD BacLight Bacterial Viability Kit for rapid determination of bacterial load. Front. Microbiol. 10, 801 (2019).","journal-title":"Front. Microbiol."},{"key":"64545_CR29","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/jac\/dkh114","volume":"53","author":"B Oliva","year":"2004","unstructured":"Oliva, B., O\u2019Neill, A. J., Miller, K., Stubbings, W. & Chopra, I. Anti-staphylococcal activity and mode of action of clofazimine. J. Antimicrob. Chemother. 53, 435\u2013440 (2004).","journal-title":"J. Antimicrob. Chemother."},{"key":"64545_CR30","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/jac\/dkh476","volume":"54","author":"AJ O\u2019Neill","year":"2004","unstructured":"O\u2019Neill, A. J., Miller, K., Oliva, B. & Chopra, I. Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureus. J. Antimicrob. Chemother. 54, 1127\u20131129 (2004).","journal-title":"J. Antimicrob. Chemother."},{"key":"64545_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep07534","volume":"4","author":"R P\u00e9rez-Isidoro","year":"2014","unstructured":"P\u00e9rez-Isidoro, R., Sierra-Valdez, F. & Ruiz-Su\u00e1rez, J. Anesthetic diffusion through lipid membranes depends on the protonation rate. Sci. Rep. 4, 7534 (2014).","journal-title":"Sci. Rep."},{"key":"64545_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-12-198","volume":"12","author":"R Lood","year":"2011","unstructured":"Lood, R. & Collin, M. Characterization and genome sequencing of two Propionibacterium acnes phages displaying pseudolysogeny. BMC Genomics 12, 198 (2011).","journal-title":"BMC Genomics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64545-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64545-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64545-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T10:02:32Z","timestamp":1670320952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64545-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["64545"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-64545-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]},"assertion":[{"value":"3 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7491"}}